Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CGT4859 |
Synonyms | |
Therapy Description |
Limited information is currently available on CGT4859, a putative FGFR2/3 inhibitor (Jan 2025). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CGT4859 | CGT-4859|CGT 4859 | FGFR2 Inhibitor 24 FGFR3 Inhibitor 20 | Limited information is currently available on CGT4859, a putative FGFR2/3 inhibitor (Jan 2025). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06777316 | Phase Ib/II | CGT4859 | A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors | Recruiting | USA | 0 |